What We Do. We are helping to transform women's health with the discovery, development, and utilization of innovative testing options and bio-analytical solutions that help physicians assess risk, optimize patient management and improve gynecologic health outcomes for women. Our FDA-cleared products OVA1 ® and OVERA ® detect the risk of ovarian malignancy in women with adnexal masses..